CAS 519-23-3|ELLIPTICINE

Introduction:Basic information about CAS 519-23-3|ELLIPTICINE, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameELLIPTICINE
CAS Number519-23-3Molecular Weight246.307
Density1.3±0.1 g/cm3Boiling Point495.4±40.0 °C at 760 mmHg
Molecular FormulaC17H14N2Melting Point316-318°C
MSDS/Flash Point227.1±18.6 °C

Names

Nameellipticine
SynonymMore Synonyms

ELLIPTICINE BiologicalActivity

DescriptionEllipticine hydrochloride is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
Related CatalogResearch Areas >>CancerNatural Products >>Alkaloid
Target

Topoisomerase II

In VitroEllipticine is a potent antineoplastic agent exhibiting the multimodal mechanism of its action. The mechanisms of ellipticine antitumor, mutagenic and cytotoxic activities are suggested to be intercalation into DNA and inhibition of DNA topoisomerase II activity. Another mode of ellipticine action is the formation of covalent DNA adducts mediated by its oxidation with cytochromes P450 (CYP) and peroxidases[1]. Ellipticine can also act as an inhibitor or inducer of biotransformation enzymes, thereby modulating its own metabolism leading to its genotoxic and pharmacological effects. Treatment of cells with ellipticine results in inhibition of cell growth and proliferation. This effect is associated with formation of two covalent ellipticine-derived DNA adducts[2].
In VivoEllipticine treatment results in ellipticine-derived DNA adduct generation in several healthy organs (liver, kidney, lung, spleen, breast, heart and brain) and in DNA of mammary adenocarcinoma. The levels of ellipticine-derived DNA adducts generated in these adenocarcinomas are almost 2-fold higher than in normal healthy mammary tissue. The induced expression of cytochrome b5 protein in liver of rats treated with ellipticine suggests that cytochrome b5 may modulate the CYP-mediated bioactivation and detoxification of ellipticine[3].
Cell AssayThe cytotoxicity of ellipticine is determined by MTT test. Ellipticine is dissolved in DMSO (1 mM) and diluted in culture medium to final concentrations of 0, 0.1, 1, 5 or 10 μM. Cells in exponential growth are seeded at 1×104 per well in a 96-well microplate. After incubation the MTT solution is added, the microplates are incubated for 4 hours and cells lysed in 50% N,N-dimethylformamide containing 20% of sodium dodecyl sulfate (SDS), pH 4.5. The absorbance at 570 nm is measured. The mean absorbance of medium controls is subtracted as a background. The viability of control cells is taken as 100% and the values of treated cells are calculated as a percentage of control. The IC50 values are calculated using linear regression of the dose-log response curves[2].
References

[1]. Stiborova M, et al. Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006 Jul;150(1):13-23.

[2]. Stiborova M, et al. Ellipticine cytotoxicity to cancer cell lines - a comparative study. Interdiscip Toxicol. 2011 Jun;4(2):98-105.

[3]. Stiborova M, et al. The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, Hepatic Cytochrome P450 Reductase Null (HRN?) mice and pure enzymes. Int J Mol Sci. 2014 Dec 25;16(1):284-306.

Chemical & Physical Properties

Density1.3±0.1 g/cm3
Boiling Point495.4±40.0 °C at 760 mmHg
Melting Point316-318°C
Molecular FormulaC17H14N2
Molecular Weight246.307
Flash Point227.1±18.6 °C
Exact Mass246.115692
PSA28.68000
LogP4.80
Vapour Pressure0.0±1.2 mmHg at 25°C
Index of Refraction1.777
Storage condition2-8°C
Water SolubilityDMSO: soluble

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UU8825000
CHEMICAL NAME :
6H-Pyrido(4,3-b)carbazole, 5,11-dimethyl-
CAS REGISTRY NUMBER :
519-23-3
BEILSTEIN REFERENCE NO. :
0221300
LAST UPDATED :
199709
DATA ITEMS CITED :
26
MOLECULAR FORMULA :
C17-H14-N2
MOLECULAR WEIGHT :
246.33
WISWESSER LINE NOTATION :
T D6 B656 FN LMJ C1 J1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
178 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
19500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :
DNA adduct
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
3 mg/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 23,379,1978

Safety Information

Hazard CodesT
Risk Phrases25
Safety PhrasesS45
RIDADRUN 3462 6.1/PG 3
WGK Germany3
RTECSUU8825000
Packaging GroupIII
Hazard Class6.1(b)
HS Code2933990090

Customs

HS Code2933990090
Summary2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Synonyms

MFCD00010524
5,11-Dimethyl-6H-pyrido[4,3-b]carbazole
6H-Pyrido[4,3-b]carbazole, 5,11-dimethyl-
EINECS 208-264-0
tcmdc-125546
ELLIPTICINE
Elliptisine
CAS 50262-49-2|P-BUTYRYLOXYBENZALDEHYDE
CAS 580-35-8|Pyridine,2,4,6-triphenyl-
Recommended......
TOP